Phase-0 Microdosing Network Board of Directors


Saskia N. de Wildt, M.D., Ph.D.

Dr. de Wildt is a pediatric intensivist and associate professor in pediatric clinical pharmacology at Erasmus MC Sophia Children’s Hospital and serves as the Director of PharmaKids, the Erasmus Expertise Ctr for Pediatric Therapeutics and the Medicines for Children Research Ctr-the Netherlands. She received her Ph.D. from Erasmus Univ and trained as a clinical pharmacologist at the Hosp for Sick Children in Toronto. Current Dutch Research Council and European Union supported research focuses on developmental pharmacology, more specifically on drug metabolism, drug transport, and with a special interest in sedative and analgesic drugs. Dr de Wildt published over 65 international peer-reviewed papers in the field of pediatric pharmacology/intensive care. As a primary investigator, Dr. de Wildt holds currently 3 million euros in research grants, of which >2 million euros from the Dutch Research Council, ZonMW, and the EU.